Pharmacological Reports

Aims & Scope

Pharmacological Reports is the official journal of Maj Institute of Pharmacology Polish Academy of Sciences.

Pharmacological Reports is an open forum for recent developments in experimental and clinical pharmacology, dealing with the action of drugs at cellular, molecular and behavioral levels.

It publishes research articles, reviews, and short communications.

The journal guarantees rapid publication of accepted papers, comprised of fast acceptance and publication for articles.

It is a hybrid journal, offering the choice of open access, and is published bi-monthly.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.8
2024	3.60

SJR (SCImago Journal Rank)

Year	Value
2024	0.933

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	100

Journal Rank

Year	Value
2024	5415

Journal Citation Indicator

Year	Value
2024	1542

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• A review on Alzheimer's disease pathophysiology and its management: an update

  Citation: 1282

  Authors: Anil, Arti

• Nanoparticles as drug delivery systems

  Citation: 1141

  Authors: Agnieszka Z., Katarzyna, Karolina H., Halina

• Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron

  Citation: 628

  Authors: Tomáš, Martin, Olga, Michaela, Radomír, Vladimír

• ICAM-1 signaling in endothelial cells

  Citation: 520

  Authors: Charlotte, Sabine

• Drug repurposing approach to fight COVID-19

  Citation: 385

  Authors: Thakur Uttam, Subhashree, Madhu Cholenahalli, Manickam, Dinesh, Raj Kumar

• Therapeutic strategies for Alzheimer's disease in clinical trials

  Citation: 379

  Authors: Justyna, Jakub, Dawid, Barbara

• Lipoic acid – biological activity and therapeutic potential

  Citation: 351

  Authors: Anna, Halina, Aleksandra, Paulina, Elżbieta, Beata

• Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide

  Citation: 347

  Authors: Krzysztof, Dariusz, Bożena, Anna, Sebastian, Bogusław

• Treatment of inflammatory bowel disease (IBD)

  Citation: 326

  Authors: Anand B., Sunita

• COX-2 as a target for cancer chemotherapy

  Citation: 265

  Authors: Nilanjan, Rituparna, Vivekananda, Subhash C.

---